(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are National American University Holdings, MicroStrategy, and GameStop.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | National American University Holdings (NAUH) | 0.08 | 53.55% | 2024-03-25 05:08:08 |
| 2 | MicroStrategy (MSTR) | 1856.00 | 21.86% | 2024-03-25 15:02:11 |
| 3 | GameStop (GME) | 15.12 | 15.42% | 2024-03-25 15:56:33 |
| 4 | Lifeway Foods (LWAY) | 16.49 | 11.72% | 2024-03-24 21:11:07 |
| 5 | Methes Energies International Ltd (MEIL) | 0.04 | 11.66% | 2024-03-24 23:23:08 |
| 6 | Nikola (NKLA) | 0.74 | 11.22% | 2024-03-25 14:50:28 |
| 7 | Coinbase (COIN) | 279.71 | 9.47% | 2024-03-25 15:04:11 |
| 8 | Riot Blockchain (RIOT) | 12.44 | 9.08% | 2024-03-25 14:50:52 |
| 9 | Full House Resorts (FLL) | 5.49 | 8.07% | 2024-03-25 15:00:26 |
| 10 | American Public Education (APEI) | 14.66 | 8.03% | 2024-03-25 15:11:27 |
The three biggest losers today are NanoString Technologies, Canopy Growth, and Aurora Cannabis.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | NanoString Technologies (NSTG) | 0.11 | -37.43% | 2024-03-25 07:43:07 |
| 2 | Canopy Growth (CGC) | 6.20 | -19.38% | 2024-03-25 15:14:05 |
| 3 | Aurora Cannabis (ACB) | 4.14 | -14.81% | 2024-03-25 15:03:44 |
| 4 | Groupon (GRPN) | 13.11 | -9.02% | 2024-03-25 15:00:53 |
| 5 | MIND Technology (MIND) | 4.68 | -8.24% | 2024-03-25 01:14:07 |
| 6 | Nova Lifestyle (NVFY) | 2.82 | -7.24% | 2024-03-25 09:09:08 |
| 7 | Tilray (TLRY) | 2.15 | -6.93% | 2024-03-25 15:06:59 |
| 8 | MacroGenics (MGNX) | 14.48 | -5.91% | 2024-03-25 01:09:08 |
| 9 | Afya (AFYA) | 19.41 | -5.55% | 2024-03-25 15:04:37 |
| 10 | Oramed Pharmaceuticals (ORMP) | 2.77 | -4.98% | 2024-03-25 13:14:07 |
Winners today
1. National American University Holdings (NAUH) – 53.55%
National American University Holdings, Inc. owns and operates National American University (NAU) that provides professional and technical postsecondary education primarily for working adults and other non-traditional students in the United States. It operates in two segments, NAU and Other. The company offers diploma, associate, baccalaureate, master's, and doctoral degree programs in business-related disciplines, such as accounting, management, business administration, and information technology; healthcare-related disciplines, including occupational therapy, medical assisting, nursing, surgical technology, and healthcare information and management; legal-related disciplines comprising paralegal, criminal justice, and professional legal studies; and higher education. As of July 31, 2019, it operated five 33 educational sites in Colorado, Indiana, Kansas, South Dakota, and Texas; and distance learning service centers and administration offices in Rapid City, South Dakota, as well as through the Internet. The company also engages in the real estate business, which rents apartment units; and develops and sells condominium units in the Fairway Hills Planned Residential Development area of Rapid City, South Dakota. National American University Holdings, Inc. was founded in 1941 and is headquartered in Rapid City, South Dakota.
NASDAQ ended the session with National American University Holdings rising 53.55% to $0.08 on Monday while NASDAQ fell 0.27% to $16,384.47.
Earnings Per Share
As for profitability, National American University Holdings has a trailing twelve months EPS of $0.17.
PE Ratio
National American University Holdings has a trailing twelve months price to earnings ratio of 0.47. Meaning, the purchaser of the share is investing $0.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -183.64%.
Volume
Today’s last reported volume for National American University Holdings is 403 which is 96.1% below its average volume of 10354.
More news about National American University Holdings.
2. MicroStrategy (MSTR) – 21.86%
MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions. The company also provides MicroStrategy Support that helps customers achieve their system availability and usage goals through highly responsive troubleshooting and assistance; MicroStrategy Consulting, which provides architecture and implementation services to help customers realize their desired results; and MicroStrategy Education that offers free and paid learning options. In addition, it engages in the development of bitcoin. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
NASDAQ ended the session with MicroStrategy rising 21.86% to $1,856.00 on Monday while NASDAQ slid 0.27% to $16,384.47.
Earnings Per Share
As for profitability, MicroStrategy has a trailing twelve months EPS of $26.35.
PE Ratio
MicroStrategy has a trailing twelve months price to earnings ratio of 70.44. Meaning, the purchaser of the share is investing $70.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.17%.
Volatility
MicroStrategy’s last week, last month’s, and last quarter’s current intraday variation average was 0.37%, 5.02%, and 6.57%.
MicroStrategy’s highest amplitude of average volatility was 5.88% (last week), 10.40% (last month), and 6.57% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
MicroStrategy’s EBITDA is 53.15.
Moving Average
MicroStrategy’s value is way higher than its 50-day moving average of $686.74 and way above its 200-day moving average of $470.45.
More news about MicroStrategy.
3. GameStop (GME) – 15.42%
GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It also sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.
NYSE ended the session with GameStop rising 15.42% to $15.12 on Monday, following the last session’s downward trend. NYSE dropped 0.19% to $18,077.15, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, GameStop has a trailing twelve months EPS of $-0.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.65%.
Yearly Top and Bottom Value
GameStop’s stock is valued at $15.12 at 17:32 EST, way below its 52-week high of $27.65 and way higher than its 52-week low of $11.83.
Earnings Before Interest, Taxes, Depreciation, and Amortization
GameStop’s EBITDA is -1.07.
More news about GameStop.
4. Lifeway Foods (LWAY) – 11.72%
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, Glen Oaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was incorporated in 1986 and is based in Morton Grove, Illinois.
NASDAQ ended the session with Lifeway Foods rising 11.72% to $16.49 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Lifeway Foods has a trailing twelve months EPS of $0.75.
PE Ratio
Lifeway Foods has a trailing twelve months price to earnings ratio of 21.99. Meaning, the purchaser of the share is investing $21.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.05%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Lifeway Foods’s EBITDA is 1.45.
Volume
Today’s last reported volume for Lifeway Foods is 241555 which is 326.67% above its average volume of 56613.
Yearly Top and Bottom Value
Lifeway Foods’s stock is valued at $16.49 at 17:32 EST, under its 52-week high of $17.33 and way above its 52-week low of $5.61.
More news about Lifeway Foods.
5. Methes Energies International Ltd (MEIL) – 11.66%
Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Methes Energies International Ltd rising 11.66% to $0.04 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 75.8%, now sitting on 3.72M for the twelve trailing months.
Moving Average
Methes Energies International Ltd’s worth is way below its 50-day moving average of $0.06 and below its 200-day moving average of $0.04.
Yearly Top and Bottom Value
Methes Energies International Ltd’s stock is valued at $0.04 at 17:32 EST, way under its 52-week high of $0.10 and way above its 52-week low of $0.02.
Volume
Today’s last reported volume for Methes Energies International Ltd is 800 which is 98.31% below its average volume of 47558.
More news about Methes Energies International Ltd.
6. Nikola (NKLA) – 11.22%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. The company operates in truck and energy units. It commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. In addition, it develops a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. Further, its products include Nikola Tre Class 8 truck and the Nikola's Class 8 FCEV. Additionally, the company assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola rising 11.22% to $0.74 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -138.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 75.7%, now sitting on 35.84M for the twelve trailing months.
Sales Growth
Nikola’s sales growth is 20.1% for the present quarter and 54.9% for the next.
Yearly Top and Bottom Value
Nikola’s stock is valued at $0.74 at 17:32 EST, way under its 52-week high of $3.71 and way above its 52-week low of $0.52.
Moving Average
Nikola’s worth is higher than its 50-day moving average of $0.73 and way below its 200-day moving average of $1.17.
More news about Nikola.
7. Coinbase (COIN) – 9.47%
Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase rising 9.47% to $279.71 on Monday while NASDAQ slid 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $0.36.
PE Ratio
Coinbase has a trailing twelve months price to earnings ratio of 776.97. Meaning, the purchaser of the share is investing $776.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.74%.
More news about Coinbase.
8. Riot Blockchain (RIOT) – 9.08%
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain rising 9.08% to $12.44 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-0.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.25%.
Yearly Top and Bottom Value
Riot Blockchain’s stock is valued at $12.44 at 17:32 EST, way under its 52-week high of $20.65 and way higher than its 52-week low of $5.33.
Volatility
Riot Blockchain’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.04%, a negative 1.11%, and a positive 5.32%.
Riot Blockchain’s highest amplitude of average volatility was 5.87% (last week), 4.98% (last month), and 5.32% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Riot Blockchain’s EBITDA is 8.
More news about Riot Blockchain.
9. Full House Resorts (FLL) – 8.07%
Full House Resorts, Inc. owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. It operates through Midwest & South, West, and Contracted Sports Wagering segments. The company's properties include American Place in Waukegan, Illinois; Silver Slipper Casino and Hotel in Hancock County, Mississippi; Rising Star Casino Resort in Rising Sun, Indiana; Bronco Billy's Casino and Chamonix Casino Hotel in Cripple Creek, Colorado; Stockman's Casino in Fallon, Nevada; and Grand Lodge Casino, located within the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. It also offers online sports wagering services. The company was incorporated in 1987 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Full House Resorts rising 8.07% to $5.49 on Monday, after four sequential sessions in a row of gains. NASDAQ fell 0.27% to $16,384.47, after five sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Full House Resorts has a trailing twelve months EPS of $-0.72.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.3%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 66.4%, now sitting on 241.06M for the twelve trailing months.
More news about Full House Resorts.
10. American Public Education (APEI) – 8.03%
American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning in the United States. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 184 degree programs and 134 certificate programs in various fields of study, including nursing, national security, military studies, intelligence, homeland security, business, health science, information technology, justice studies, education, and liberal arts; and career learning opportunities in leadership, finance, human resources, and other fields of study critical to the federal government workforce. It also provides nursing-and health sciences-focused postsecondary education, pre-licensure nursing programs, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.
NASDAQ ended the session with American Public Education rising 8.03% to $14.66 on Monday while NASDAQ slid 0.27% to $16,384.47.
Earnings Per Share
As for profitability, American Public Education has a trailing twelve months EPS of $-2.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.74%.
More news about American Public Education.
Losers Today
1. NanoString Technologies (NSTG) – -37.43%
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
NASDAQ ended the session with NanoString Technologies sliding 37.43% to $0.11 on Monday, after five consecutive sessions in a row of losses. NASDAQ fell 0.27% to $16,384.47, after five consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, NanoString Technologies has a trailing twelve months EPS of $-3.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1028.56%.
Volume
Today’s last reported volume for NanoString Technologies is 21428500 which is 19.67% above its average volume of 17905200.
More news about NanoString Technologies.
2. Canopy Growth (CGC) – -19.38%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth sliding 19.38% to $6.20 on Monday, after five sequential sessions in a row of gains. NASDAQ slid 0.27% to $16,384.47, after five sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.
More news about Canopy Growth.
3. Aurora Cannabis (ACB) – -14.81%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
NYSE ended the session with Aurora Cannabis sliding 14.81% to $4.14 on Monday, after two successive sessions in a row of gains. NYSE slid 0.19% to $18,077.15, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.78.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.
More news about Aurora Cannabis.
4. Groupon (GRPN) – -9.02%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon falling 9.02% to $13.11 on Monday while NASDAQ fell 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-1.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -567.07%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 128.9% and 87.7%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Groupon’s EBITDA is -26.62.
More news about Groupon.
5. MIND Technology (MIND) – -8.24%
MIND Technology, Inc., together with its subsidiaries, provides technology to the oceanographic, hydrographic, defense, seismic and maritime security industries. It develops, manufactures, and sells proprietary products. The company's products include the GunLink seismic source acquisition and control systems that provide operators of marine seismic surveys with precise monitoring and control of energy sources; the BuoyLink RGPS tracking system, which is used to offer precise positioning of marine seismic energy sources and streamers; Digishot energy source controllers; Sleeve Gun energy sources; and SeaLink product line of marine sensors and solid streamer systems. It also provides streamer weight collars, depth and pressure transducers, air control valves, and source array systems; spare and replacement parts; and repair and engineering services, training and field service operations, and umbilical terminations, as well as side scan sonar systems and related products. The company markets its products to governmental and commercial customers through internal sales organization and a network of distributors and representatives. It serves in in the United States, Europe, Russia, CIS, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company was formerly known as Mitcham Industries, Inc. MIND Technology, Inc. was incorporated in 1987 and is headquartered in The Woodlands, Texas.
NASDAQ ended the session with MIND Technology falling 8.24% to $4.68 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, MIND Technology has a trailing twelve months EPS of $-5.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.76%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MIND Technology’s EBITDA is -42.9.
Yearly Top and Bottom Value
MIND Technology’s stock is valued at $4.68 at 17:32 EST, way under its 52-week high of $81.00 and way higher than its 52-week low of $4.01.
Moving Average
MIND Technology’s worth is way under its 50-day moving average of $5.91 and way below its 200-day moving average of $30.10.
Sales Growth
MIND Technology’s sales growth for the current quarter is 8.8%.
More news about MIND Technology.
6. Nova Lifestyle (NVFY) – -7.24%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living rooms, dining rooms, bedrooms, and home offices. Its products include sofas, chairs, dining tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinics, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
NASDAQ ended the session with Nova Lifestyle dropping 7.24% to $2.82 on Monday, after three successive sessions in a row of gains. NASDAQ dropped 0.27% to $16,384.47, after five consecutive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Nova Lifestyle has a trailing twelve months EPS of $-8.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.88%.
Yearly Top and Bottom Value
Nova Lifestyle’s stock is valued at $2.82 at 17:32 EST, way under its 52-week high of $6.38 and way higher than its 52-week low of $1.45.
Volume
Today’s last reported volume for Nova Lifestyle is 343059 which is 83.01% below its average volume of 2020120.
Moving Average
Nova Lifestyle’s worth is way above its 50-day moving average of $2.06 and way higher than its 200-day moving average of $2.31.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nova Lifestyle’s EBITDA is -7.62.
More news about Nova Lifestyle.
7. Tilray (TLRY) – -6.93%
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
NASDAQ ended the session with Tilray sliding 6.93% to $2.15 on Monday while NASDAQ dropped 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-2.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36%.
Moving Average
Tilray’s value is way above its 50-day moving average of $1.93 and above its 200-day moving average of $2.03.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tilray’s EBITDA is -151.76.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 97.4% and 80%, respectively.
Volume
Today’s last reported volume for Tilray is 53270400 which is 122.81% above its average volume of 23908000.
More news about Tilray.
8. MacroGenics (MGNX) – -5.91%
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics to treat cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase II/III clinical trial for the treatment of breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; Enoblituzumab, a monoclonal antibody that targets B7-H3; and Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3. In addition, it is developing MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company's non-immuno-oncology clinical product candidates include MGD014, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; Janssen Biotech, Inc.; and Alligator Bioscience AB (publ). The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
NASDAQ ended the session with MacroGenics sliding 5.91% to $14.48 on Monday while NASDAQ slid 0.27% to $16,384.47.
Earnings Per Share
As for profitability, MacroGenics has a trailing twelve months EPS of $-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.15%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 85.3%, now sitting on 58.75M for the twelve trailing months.
Sales Growth
MacroGenics’s sales growth for the current quarter is negative 36.1%.
More news about MacroGenics.
9. Afya (AFYA) – -5.55%
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
NASDAQ ended the session with Afya sliding 5.55% to $19.41 on Monday, after four successive sessions in a row of losses. NASDAQ slid 0.27% to $16,384.47, after five successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Afya has a trailing twelve months EPS of $0.79.
PE Ratio
Afya has a trailing twelve months price to earnings ratio of 24.57. Meaning, the purchaser of the share is investing $24.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.15%.
Sales Growth
Afya’s sales growth is 21.9% for the ongoing quarter and 14.6% for the next.
More news about Afya.
10. Oramed Pharmaceuticals (ORMP) – -4.98%
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
NASDAQ ended the session with Oramed Pharmaceuticals falling 4.98% to $2.77 on Monday while NASDAQ slid 0.27% to $16,384.47.
Earnings Per Share
As for profitability, Oramed Pharmaceuticals has a trailing twelve months EPS of $0.14.
PE Ratio
Oramed Pharmaceuticals has a trailing twelve months price to earnings ratio of 19.75. Meaning, the purchaser of the share is investing $19.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.24%.
More news about Oramed Pharmaceuticals.
Stay up to date with our winners and losers daily report
